Last 12 months
Inside the activity.
0 purchase rows · 78 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 35 |
| Mar 2026 | 0 | 13 |
| Apr 2026 | 0 | 9 |
| May 2026 | 0 | 12 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 3 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 22, 2016 Filed Dec 20, 2016 21:29 UTC |
VAGELOS P ROYDirector · Chairman of the Board
|
GiftCommon Stock | 59,788 | $0.00 | $0.00 |
DisclosureSEC source: 0001237899-16-000095 · edgardoc.xml · nonDerivative · entry 1 VAGELOS P ROY · CIK 0001013064 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 414,156 Read SEC document |
| November 15, 2016 Filed Nov 16, 2016 21:21 UTC |
RYAN ARTHUR FDirector
|
GiftCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001237899-16-000084 · edgardoc.xml · nonDerivative · entry 2 RYAN ARTHUR F · CIK 0001187443 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,500 Read SEC document |
| November 15, 2016 Filed Nov 16, 2016 21:21 UTC |
RYAN ARTHUR FDirector
|
SaleCommon Stock | 2,000 | $429.34 | $858,680.00 |
DisclosureSEC source: 0001237899-16-000084 · edgardoc.xml · nonDerivative · entry 1 RYAN ARTHUR F · CIK 0001187443 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,500 Read SEC document |
| November 14, 2016 Filed Nov 15, 2016 21:08 UTC |
GOLDSTEIN JOSEPH LDirector
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 2,125 | $0.00 Strike: $273.67 | $0.00 |
DisclosureSEC source: 0001237899-16-000083 · edgardoc.xml · derivative · entry 3 GOLDSTEIN JOSEPH L · CIK 0001225474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,500 Underlying: Common Stock · 2,125 shares Expires 2024-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F2 · derivative.exercise_date: The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant. Read SEC document |
| November 14, 2016 Filed Nov 15, 2016 21:08 UTC |
GOLDSTEIN JOSEPH LDirector
|
SaleCommon Stock | 2,125 | $450.00 | $956,250.00 |
DisclosureSEC source: 0001237899-16-000083 · edgardoc.xml · nonDerivative · entry 2 GOLDSTEIN JOSEPH L · CIK 0001225474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,000 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Read SEC document |
| November 14, 2016 Filed Nov 15, 2016 21:08 UTC |
GOLDSTEIN JOSEPH LDirector
|
Exercise / conversionCommon Stock | 2,125 | $273.67 | $581,548.75 |
DisclosureSEC source: 0001237899-16-000083 · edgardoc.xml · nonDerivative · entry 1 GOLDSTEIN JOSEPH L · CIK 0001225474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,125 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Read SEC document |
| November 07, 2016 Filed Nov 9, 2016 21:10 UTC |
VAGELOS P ROYDirector · Chairman of the Board
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 76,895 | $0.00 Strike: $20.32 | $0.00 |
DisclosureSEC source: 0001237899-16-000082 · edgardoc.xml · derivative · entry 9 VAGELOS P ROY · CIK 0001013064 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 76,895 shares Expires 2016-12-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant. Read SEC document |
| November 07, 2016 Filed Nov 9, 2016 21:10 UTC |
VAGELOS P ROYDirector · Chairman of the Board
|
Tax withholdingCommon Stock | 37,388 | $355.52 | $13,292,181.76 |
DisclosureSEC source: 0001237899-16-000082 · edgardoc.xml · nonDerivative · entry 3 VAGELOS P ROY · CIK 0001013064 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 473,944 Read SEC document |
| November 07, 2016 Filed Nov 9, 2016 21:10 UTC |
VAGELOS P ROYDirector · Chairman of the Board
|
Tax withholdingCommon Stock | 4,394 | $355.52 | $1,562,154.88 |
DisclosureSEC source: 0001237899-16-000082 · edgardoc.xml · nonDerivative · entry 2 VAGELOS P ROY · CIK 0001013064 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 511,332 Read SEC document |
| November 07, 2016 Filed Nov 9, 2016 21:10 UTC |
VAGELOS P ROYDirector · Chairman of the Board
|
Exercise / conversionCommon Stock | 76,895 | $20.32 | $1,562,506.40 |
DisclosureSEC source: 0001237899-16-000082 · edgardoc.xml · nonDerivative · entry 1 VAGELOS P ROY · CIK 0001013064 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 515,726 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 07, 2016 Filed Dec 20, 2016 21:28 UTC |
STAHL NEILEVP Research and Development
|
GiftCommon Stock | 7,876 | $0.00 | $0.00 |
DisclosureSEC source: 0001237899-16-000094 · edgardoc.xml · nonDerivative · entry 2 STAHL NEIL · CIK 0001226689 · EVP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,950 Read SEC document |
| October 03, 2016 Filed Nov 9, 2016 21:10 UTC |
VAGELOS P ROYDirector · Chairman of the Board
|
GiftCommon Stock | 531 | $0.00 | $0.00 |
DisclosureSEC source: 0001237899-16-000082 · edgardoc.xml · nonDerivative · entry 5 VAGELOS P ROY · CIK 0001013064 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · by CLAT Disclosed balance after: 151,825 Read SEC document |
| September 09, 2016 Filed Sep 12, 2016 20:25 UTC |
Zoghbi Huda YDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 15,353 | $0.00 Strike: $391.92 | $0.00 |
DisclosureSEC source: 0001104659-16-144227 · a4.xml · derivative · entry 1 Zoghbi Huda Y · CIK 0001681643 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,353 Underlying: Common Stock · 15,353 shares Expires 2026-09-09 F1 · derivative.exercise_date: The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant. Read SEC document |
| September 09, 2016 Filed Sep 12, 2016 20:24 UTC |
Bassler Bonnie LDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 15,353 | $0.00 Strike: $391.92 | $0.00 |
DisclosureSEC source: 0001104659-16-144226 · a4.xml · derivative · entry 1 Bassler Bonnie L · CIK 0001683607 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,353 Underlying: Common Stock · 15,353 shares Expires 2026-09-09 F1 · derivative.exercise_date: The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant. Read SEC document |
| July 21, 2016 Filed Dec 19, 2016 21:09 UTC |
YANCOPOULOS GEORGEDirector · President Regeneron Laboratori
|
GiftCommon Stock | 500,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001237899-16-000087 · edgardoc.xml · nonDerivative · entry 5 YANCOPOULOS GEORGE · CIK 0001226690 · Director · President Regeneron Laboratori 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 67,976 Read SEC document |
| July 21, 2016 Filed Dec 19, 2016 21:09 UTC |
YANCOPOULOS GEORGEDirector · President Regeneron Laboratori
|
GiftCommon Stock | 500,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001237899-16-000087 · edgardoc.xml · nonDerivative · entry 4 YANCOPOULOS GEORGE · CIK 0001226690 · Director · President Regeneron Laboratori 10b5-1 filing: Not disclosed Ownership: Indirect · by GRAT Disclosed balance after: 500,000 Read SEC document |
| July 01, 2016 Filed Nov 9, 2016 21:10 UTC |
VAGELOS P ROYDirector · Chairman of the Board
|
GiftCommon Stock | 608 | $0.00 | $0.00 |
DisclosureSEC source: 0001237899-16-000082 · edgardoc.xml · nonDerivative · entry 4 VAGELOS P ROY · CIK 0001013064 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · by CLAT Disclosed balance after: 152,356 Read SEC document |
| May 16, 2016 Filed Dec 19, 2016 21:15 UTC |
Powchik PeterSVP Clinical Development & Reg
|
GiftCommon Stock | 2,459 | $0.00 | $0.00 |
DisclosureSEC source: 0001237899-16-000089 · edgardoc.xml · nonDerivative · entry 4 Powchik Peter · CIK 0001377247 · SVP Clinical Development & Reg 10b5-1 filing: Not disclosed Ownership: Indirect · by trust for daughte Disclosed balance after: 2,459 F2 · ownership.nature: By a trust for the benefit of the reporting person's daughter of which the reporting person's spouse is trustee. Read SEC document |
| May 16, 2016 Filed Dec 19, 2016 21:15 UTC |
Powchik PeterSVP Clinical Development & Reg
|
GiftCommon Stock | 2,459 | $0.00 | $0.00 |
DisclosureSEC source: 0001237899-16-000089 · edgardoc.xml · nonDerivative · entry 3 Powchik Peter · CIK 0001377247 · SVP Clinical Development & Reg 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust for Son Disclosed balance after: 2,459 F1 · ownership.nature: By a trust for the benefit of the reporting person's son of which the reporting person's spouse is trustee. Read SEC document |
| May 16, 2016 Filed Dec 19, 2016 21:15 UTC |
Powchik PeterSVP Clinical Development & Reg
|
GiftCommon Stock | 2,459 | $0.00 | $0.00 |
DisclosureSEC source: 0001237899-16-000089 · edgardoc.xml · nonDerivative · entry 2 Powchik Peter · CIK 0001377247 · SVP Clinical Development & Reg 10b5-1 filing: Not disclosed Ownership: Indirect · by GRAT Disclosed balance after: 0 Read SEC document |
| May 16, 2016 Filed Dec 19, 2016 21:15 UTC |
Powchik PeterSVP Clinical Development & Reg
|
GiftCommon Stock | 2,459 | $0.00 | $0.00 |
DisclosureSEC source: 0001237899-16-000089 · edgardoc.xml · nonDerivative · entry 1 Powchik Peter · CIK 0001377247 · SVP Clinical Development & Reg 10b5-1 filing: Not disclosed Ownership: Indirect · by GRAT Disclosed balance after: 2,459 Read SEC document |
| February 19, 2016 Filed Dec 20, 2016 21:28 UTC |
STAHL NEILEVP Research and Development
|
GiftCommon Stock | 1,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001237899-16-000094 · edgardoc.xml · nonDerivative · entry 1 STAHL NEIL · CIK 0001226689 · EVP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,470 Read SEC document |
| December 17, 2015 Filed Dec 14, 2018 21:21 UTC |
YANCOPOULOS GEORGEDirector · President and CSO
|
GiftCommon Stock | 1,921 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-073103 · a4.xml · nonDerivative · entry 13 YANCOPOULOS GEORGE · CIK 0001226690 · Director · President and CSO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 569,897 Read SEC document |
| December 17, 2015 Filed Dec 14, 2018 21:21 UTC |
YANCOPOULOS GEORGEDirector · President and CSO
|
GiftCommon Stock | 1,921 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-073103 · a4.xml · nonDerivative · entry 2 YANCOPOULOS GEORGE · CIK 0001226690 · Director · President and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,000 Read SEC document |
| November 02, 2015 Filed Dec 14, 2018 21:21 UTC |
YANCOPOULOS GEORGEDirector · President and CSO
|
GiftCommon Stock | 43,348 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-073103 · a4.xml · nonDerivative · entry 12 YANCOPOULOS GEORGE · CIK 0001226690 · Director · President and CSO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 612,936 Read SEC document |
| November 02, 2015 Filed Dec 14, 2018 21:21 UTC |
YANCOPOULOS GEORGEDirector · President and CSO
|
GiftCommon Stock | 43,348 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-073103 · a4.xml · nonDerivative · entry 1 YANCOPOULOS GEORGE · CIK 0001226690 · Director · President and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,000 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.